Author(s): Ashok B. Patel, Shivangi V. Abhangi, Amitkumar J. Vyas, Ajay I. Patel, Urvi J. Chotaliya

Email(s): shivangiabhngi.087@gmail.com

DOI: 10.52711/2231-5659.2024.00014   

Address: Ashok B. Patel2, Shivangi V. Abhangi1, Amitkumar J. Vyas1, Ajay I. Patel1, Urvi J. Chotaliya1
1Department of QA, B.K. Mody Government Pharmacy College, Rajkot, India.
2Government Pharmacy College, Gandhinagar.
*Corresponding Author

Published In:   Volume - 14,      Issue - 1,     Year - 2024


ABSTRACT:
The World Health Organization (WHO) initially released its list in 1977, marking the beginning of the Essential Medicine Concept, a significant advancement in medical treatment. One of the most cost-effective aspects of modern healthcare is the appropriate use of vital medications. From expert judgement to evidence-based selection, the selection process has developed. In 1996, the first Indian list was published. Particularly in the public sector and in low- and lower middle-income countries, Essential Medicine Policies (EMLs) have had an impact on the provision of medications and led to a higher availability of essential vs non-essential medicines. Even yet, fair access is not guaranteed by the accessibility of necessary medications, particularly in the public sector.


Cite this article:
Ashok B. Patel, Shivangi V. Abhangi, Amitkumar J. Vyas, Ajay I. Patel, Urvi J. Chotaliya. Ashok B. Patel, Shivangi V. Abhangi, Amitkumar J. Vyas, Ajay I. Patel, Urvi J. Chotaliya. Asian Journal of Research in Pharmaceutical Sciences. Sci. 2024; 14(1):87-1. doi: 10.52711/2231-5659.2024.00014

Cite(Electronic):
Ashok B. Patel, Shivangi V. Abhangi, Amitkumar J. Vyas, Ajay I. Patel, Urvi J. Chotaliya. Ashok B. Patel, Shivangi V. Abhangi, Amitkumar J. Vyas, Ajay I. Patel, Urvi J. Chotaliya. Asian Journal of Research in Pharmaceutical Sciences. Sci. 2024; 14(1):87-1. doi: 10.52711/2231-5659.2024.00014   Available on: https://ajpsonline.com/AbstractView.aspx?PID=2024-14-1-14


REFERENCE:
1.    WHO Expert Committee. The Selection and Use of Essential Medicines; report of the WHO Expert Committee. World Health Organization, Geneva, Switzerland, 2002.
2.    World Health Organization. Promoting rational use of medicines : core components. 2002.
3.    Bansal D and Purohit V. Accessibility and use of essential medicines in health care: Current progress and challenges in India. Journal of Pharmacology and Pharmacotherapeutics. 2013: 4.
4.    Greene JA. Making medicines essential: the emergent centrality of pharmaceuticals in global health. BioSocieties. 2011; 6: 10–33.
5.    Mirza Z. Thirty years of essential medicines in primary health care. East Mediterranean Health Journal. 2008; 14: 74–81.
6.    MDS-3: Managing access to Medicines and Health Technologies. Management Sciences for Health Arlington, 2012.
7.    WHO Expert Committee on the Selection of Essential Drugs and World Health Organization. The selection of essential drugs: report of a WHO expert committee.  Geneva, 1997.
8.    Pammolli F, Dreifuss R, Mashelkar A and Fathalla M. Public health, innovation and intellectual property rights : report of the Commission on Intellectual Property Rights, Innovation and Public Health. World Health Organization, Switzerland. 2016.
9.    Goodman and Gilman’s. The Pharmacological Basis of Therapeutics. Medical Publication Division. 2001; 376-379.
10.    Wirtz VJ, Hogerzeil HV, Gray AL, Bigdeli M. Essential medicines for universal health coverage. The Lancet. 2017; 403–476.
11.    Seiter A. A Practical Approach to Pharmaceutical Policy.” The World Bank. 2010, 5-8.
12.    WHO. Equitable access to medicines for Universal Health Coverage by 2030. World Health Organization, New Delhi, 2017.
13.    WHO Guideline on Country Pharmaceuticals Pricing Policies. World 2015.
14.    Review series on pharmaceutical pricing policies and interventions. Working Paper 1: External reference pricing. WHO/ Health Action International, 2011.
15.    Review series on pharmaceutical pricing policies and interventions. Working Paper 5: Sales Taxes on Medicines. WHO/Health Action International, 2011.
16.    Review series on pharmaceutical pricing policies and interventions. Working Paper 3: The regulation of mark-ups in the pharmaceutical supply chain. WHO/Health Action Inter. 2011.
17.    Gray AL and Suleman F. The relevance of systematic reviews on pharmaceutical policy to low- and middle-income countries. International Journal of Clinical Pharmacy. 2015, 37, 717–25.
18.    Constitution of world health organization, including amendments adopted up to 31/12/2000. Basic documents, forty-third edition, Geneva. 2001.
19.    Universal Declaration of Human Rights. United Nations, 1948.
20.    United Nations Economic and Social Council. International Covenant on Economic, Social and Cultural Rights, 1966.
21.    The right to the highest attainable standard of health. Economic and Social and culture rights,  2000.
22.    WHO Universal health coverage. World Health Organization, 2015.
23.    Kessides I, Miniaci N, Scarpa C and Valbones P. Toward defining and measuring the affordability of public utility services. World Bank Group, 2009.
24.    Niens LM, Van E, Cameron A, Ewen M, Laing R and Brouwer WB. Practical measurement of affordability: an application to medicines.  Bull World Health Organ. 2012; 90:  219–27.
25.    Cameron A, Ewen M, Ross-Degnan D, Ball D and Laing R. Medicine prices, availability, and affordability in 36 developing and middle income countries: a secondary analysis. The Lancet. 2009; 373: 240–49.
26.    We can end poverty. Millennium Development Goals and beyond 2015.
27.    Paul F, Julio F and George A. Expansion of cancer care and control in countries of low and middle income: a call to action. The Lancet. 2010, 376, 1186-1193.
28.    A brief review on essential medicine, September 2022, https://journalsofindia.com/national-lists-of-essential-medicines-nlem-2022/
29.    A brief review on essential medicine, September 2022, https://www.ndtv.com/india-news/national-list-of-essential-medicines-all-you-need-to-know-about-it-3340499
30.    A brief review on essential medicine, September 2022, https://pib.gov.in/PressReleasePage.aspx?PRID=1858931
31.    A brief review on essential medicine, September 2022, https://indianexpress.com/article/explained/explained-health/how-govts-essential- medicines-list-ensures-supply-keeps-prices-in-check-8158024/
32.    The drugs (prices control) order, 2013
33.    R. D. Patil. An Analytical study of Weaker Section Finance and NPAs. Asian J. Management. 2011;  2(1): 14-19.
34.    G. K. Deshmukh, S. Joseph. Financial Inclusion: A Necessity. Asian J. Management. 2010;  1(2): 84-89.
35.    Jeeva S., Molly Babu. Knowledge of Diabetic Clients Regarding Self-care Practices in Management of type II Diabetes Mellitus at selected Rural Community of Bangalore, Karnataka. Asian J. Nur. Edu. and Research. 2017; 7(1):  86-94. doi: 10.5958/2349-2996.2017.00018.0
36.    Rupali P. Pethe, Alphy Rose, Seema Singh. A study to assess the Effectiveness of Planned Teaching on Knowledge Regarding safe Handling of Chemotherapeutic Drugs among the Student Nurses in selected Nursing Colleges of Vidarbha Region. Asian J. Nur. Edu. & Res. 2017;7(2):191-197.doi: 10.5958/2349-2996.2017.00039.8
37.    Manoj Kumar Sahu, Debasmita Behera. Long Term Seroprotection after Hepatitis B vaccination. Asian J. Nur. Edu. and Research. 2017; 7(2): 255-260. doi: 10.5958/2349-2996.2017.00053.2
38.    C. Rajeswari, Sugavana Selvi, Ramachandra. Anti-Retro Viral Therapy (ART) Adherence and Factors affecting Adherence among People living with HIV (PLHIVs). Asian J. Nur. Edu. and Research. 2017; 7(3): 337-340. doi: 10.5958/2349-2996.2017.00067.2
39.    Dibyajyoti Saha, Ankit Tamrakar, Mayukh Jana, Supradip Mandal. Skin Cancer: Dance of Death. Asian J. Pharm. Res.  2011; 1(2): 34-36.
40.    Ravindra B. Saudagar, Nachiket S. Dighe, Deepak S. Musmade, Vinayak M. Gaware, D. A. Jain. SERM’s in Treatment of Breast Cancer. Asian J. Pharm. Res.  2011; 1(4): 81-86.
41.    Lalit Kumar, Rajan, Vivek Sharma. Tuberculosis: A Brief Overview. Asian J. Pharm. Res. 2012; 2(2): 59-62.
42.    Mohd. Yaqub Khan, Poonam Gupta, Bipin Bihari, Vikas Kumar Verma. A Review on Diabetes and Its Management. Asian J. Pharm. Res.  2013; 3(1): 27-32.

Recomonded Articles:

Author(s): Sonam Soni, Pravin Kumar, Vinay Sagar Verma, Mukesh Sharma

DOI:         Access: Open Access Read More

Author(s): Surbhi Choursiya, Pragya Gawande, Anjali Rathore

DOI: 10.5958/2231-5659.2021.00014.X         Access: Open Access Read More

Author(s): Yogita V. Dalvi

DOI: 10.5958/2231-5659.2018.00025.5         Access: Open Access Read More

Author(s): S. S. Shuka, Bina Gidwani, R. Pandey, S. P. Rao, V. Singh, Amber Vyas

DOI:         Access: Open Access Read More

Author(s): Manohar D. Kengar, Ganesh B. Vambhurkar Asha M. Jagtap, Akshata S. Gavade, Manojkumar M. Nitalikar

DOI: 10.5958/2231-5659.2018.00043.7         Access: Open Access Read More

Author(s): Darekar A. B. , Zope Janhavi S. , Saudagar R. B.

DOI: 10.5958/2231-5659.2016.00013.8         Access: Open Access Read More

Author(s): D.M. Shinkar, Bhushan S Bhamare, R.B. Saudagar

DOI: 10.5958/2231-5659.2016.00011.4         Access: Open Access Read More

Author(s): Satheesh Kumar. G, Noorjahan, G. Sadhana Reddy, Syed Khundmeer Mujahid, T. Ashwini, V. Mahender Chary

DOI: 10.5958/2231-5659.2018.00041.3         Access: Open Access Read More

Author(s): Swati S. Talokar, Rohan R.Vakhariya

DOI: 10.5958/2231-5659.2017.00004.2         Access: Open Access Read More

Author(s): Amit Roy, Dayananda Bhoumik, Ram Kumar Sahu, Jaya Dwivedi

DOI:         Access: Open Access Read More

Author(s): Mohammad Yaqub Khan, Irfan Aziz, Imtiyaz Ahmad, Maryada Roy

DOI: 10.5958/2231-5659.2015.00029.6         Access: Open Access Read More

Author(s): Shiba S. Morris, Jeyabalan G, A. K. Jha, Shekhar Verma, Yashwant Swarnkar

DOI:         Access: Open Access Read More

Author(s): Sarmistha Rej, Madhurima Dutta, Shahid Jamal, Sumanta Das ,Sabyasachi Chatterjee

DOI:         Access: Open Access Read More

Author(s): Girish Pai K., Vamshi Krishna T., Lalit Kumar, M. Sreenivasa Reddy, Shreya Singh , Vibha V.

DOI:         Access: Open Access Read More

Author(s): Rahul Vikram Singh, Prabhakar Semwal, Taranjeet Kapoor

DOI:         Access: Open Access Read More

Author(s): Niraj Kale, Sanket Rathod, Snehal More, Namdeo Shinde

DOI: 10.52711/2231-5659.2021.00047         Access: Open Access Read More

Author(s): Deepali Anand Sutar, Bhavana. U. Jain, Manish Kondawar

DOI: 10.5958/2231-5659.2019.00022.5         Access: Open Access Read More

Asian Journal of Research in Pharmaceutical Sciences (AJPSci) is an international, peer-reviewed journal, devoted to pharmaceutical sciences....... Read more >>>

RNI: Not Available                     
DOI: 10.52711/2231-5659 


Recent Articles




Tags